Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Cost Effectiveness: Methods, Analysis And Challenges For Medical Technology Companies

This conference is to be held on June 30 to July 1, 2009 in Washington, District of Columbia. In this conference, medical technology industry and consulting experts, using illustrative case examples, will explain practical issues of cost-effectiveness, including the different types of studies, how they differ for different product categories or when used for different purposes, and what internal resources are needed to conduct or oversee such assessments.

Agenda Overview –

– Evidence and Health Technology Assesment – Terms, Concepts, and Landscape

– What Is Cost-Effectiveness

– Methods of Cost-Effectiveness Analysis

– Opportunities and Risks of Cost-Effectiveness Data

– Cost-Effectiveness in Different Product Types and Therapeutic Categories

– Policy Makers and Cost-Effectiveness Around the World

– Panel Discussion: Strategic, Tactical, and Business Considerations

– Internal Resources

– Case Study: Using Cost-Effectiveness Data in a Coverage Decision

– Case Study: Percutaneous Heart Assist

– Case Study: Deep Brain Stimulation

– Case Study: The Drug-Eluting Stent

– General Discussion

Speakers –

– Parashar Patel, Vice President, Health Economics and Reimbursement, Boston Scientific

– Gregory de Lissovoy, Senior Research Scientist, Vice President of Health Technology, United BioSource

– John Hermandez, Vice President, Neuromodulation, Health Economics and Reimbursement, Boston Scientific

– Bonnie Handke, Senior Director, Neuromodulation Reimbursement, Medtronic

– William Sarraille, Partner, Sidley Austin

– Thomas Goss, Vice President, Boston Healthcare Associates

– Liesl Cooper, VP, Global Healthcare Economics, Policy & Reimbursement, Medical Devices, Covidien

– Richard Toselli, Worldwide VP of Clinical Evidence & External Relations, DePuy Spine, a J&J Company

– Ramy Mahmoud, Chief Medical Officer, World Wide Vice President, Evidence Based Medicine, Ethicon, Inc.

– Andrew Greenfield, VP, Healthcare Solutions, Abiomed, Inc.